PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of cellbioBioMed CentralBiomed Central Web Sitesearchsubmit a manuscriptregisterthis articleCell & BioscienceJournal Front Page
 
Cell Biosci. 2011; 1: 9.
Published online Feb 25, 2011. doi:  10.1186/2045-3701-1-9
PMCID: PMC3125213
A proteomic study of TAR-RNA binding protein (TRBP)-associated factors
Ya-Hui Chi,1,3 Oliver John Semmes,2 and Kuan-Teh Jeangcorresponding author3
1Institute of Cellular and System Medicine, National Health Research Institutes, Zhunan, Taiwan
2Department of Microbiology and Molecular Cell Biology, The Leroy T. Canoles Jr. Cancer Research Center,, Eastern Virginia Medical School, Norfolk, Virginia, USA
3Molecular Virology Section, Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
corresponding authorCorresponding author.
Ya-Hui Chi: ychi/at/nhri.org.tw; Oliver John Semmes: semmesoj/at/evms.edu; Kuan-Teh Jeang: kjeang/at/niaid.nih.gov
Received January 27, 2011; Accepted February 25, 2011.
Background
The human TAR RNA-binding protein, TRBP, was first identified and cloned based on its high affinity binding to the small hairpin trans-activation responsive (TAR) RNA of HIV-1. TRBP has more recently been found to be a constituent of the RNA-induced silencing complex (RISC) serving as a Dicer co-factor in the processing of the ~70 nucleotide pre-microRNAs(miRNAs) to 21-25 nucleotide mature miRNAs.
Findings
Using co-immunoprecipitation and protein-identification by mass spectrometry, we characterized intracellular proteins that complex with TRBP. These interacting proteins include those that have been described to act in protein synthesis, RNA modifications and processing, DNA transcription, and cell proliferation.
Conclusions
Our findings provide a proteome of factors that may cooperate with TRBP in activities such as miRNA processing and in RNA interference by the RISC complex.
MicroRNAs (miRNAs) are important regulators of cellular development, differentiation, proliferation, apoptosis, metabolism, and oncogenesis [1-4]. Cellular miRNAs have also been proposed to function in restricting virus infection of cells [5-11]. The biogenesis of miRNAs in eukaryotic cells has been reviewed extensively elsewhere [12,13]. In brief, RNA polymerase II transcribed primary microRNA transcripts (pri-miRNA) are processed by Drosha in the nucleus to pre-miRNA precursors which are then processed by Dicer in the cytoplasm to mature miRNAs. In analyzing miRNA processing, it was noted that a cellular protein, TAR RNA-binding protein TRBP, binds directly to Dicer [14-17] and is important to the activity of miRNA-mediated RNA-silencing. Moreover, a TRBP-Ago2 composed RNA-induced silencing complex (RISC) has been shown to be needed for optimal miRNA-guided post-transcriptional silencing [18].
TRBP contains two double-stranded RNA binding domains (RBD) [17] and was originally characterized and cloned based on its high affinity binding to the HIV-1 small hairpin leader RNA, TAR [19-21]. Consistent with the notion of miRNA-mediated restriction of viral infection in mammalian cells, loss of TRBP activity through its sequestration by TAR RNA resulted in the enhanced replication of HIV-1 in human cells [22]. To date, TRBP is considered to act inside cells through at least three different mechanisms: it can promote the translation of TAR RNA-containing viral RNAs [23]; it can directly bind and inhibit the interferon (IFN)-induced double-stranded RNA (dsRNA)-activated protein kinase R (PKR) [24]; and as mentioned above, it can be a Dicer co-factor in the miRNA/siRNA RNAi pathway. To gain additional insight into TRBP function, we sought to identify human cellular factors that associate with TRBP. Here, using co-immunoprecipitation (co-IP) and protein-identification by mass spectrometry, we report proteins in a TRBP-proteome.
Figure Figure1A1A shows the Coomassie blue stained profile of proteins that co-IP with TRBP. After treating with RNase A, the majority (> 80%) of the co-IP products were reduced in amounts, suggesting that many TRBP-interacting partners in the co-IP are indirectly linked via RNA-association (silver stain, Figure Figure1B).1B). Next, we compared "Mock" to "TRBP" samples based on silver staining; and we excised the corresponding Coomassie blue stained protein bands that were enhanced in the TRBP sample. These bands were then analyzed by LC-MS/MS spectrometry (Figure (Figure1A).1A). The corresponding gel bands from the "Mock" sample were also excised and analyzed in parallel. By subtracting the "Mock" protein identification data from the "TRBP" protein identification data, 160 "TRBP-associated" factors were identified (Additional file 1, Table S1). The functional relevance (according to the p value computed by the Ingenuity Systems algorithm using right-tailed Fisher Exact Test) of each category of protein factors to established pathways is diagrammed in Figure Figure2,2, and the protein identities present in each functional category are listed in Table Table1.1. Similar to a previous report [25], our results show that TRBP is significantly associated with factors in the protein synthesis machinery that is constituted by the 80S ribosome [20 out of 32 proteins (RPSs; ribosomal protein, small subunits) of the 40S ribosomal subunits, and 24 out of 46 proteins (RPLs; ribosomal protein, large subunits) of the 60S ribosomal subunit were identified] [26]. Also identified were several translation elongation factors (e.g. ABCF1, EEF1A2, EIF2AK2 and EIF2S1) (Table (Table11).
Figure 1
Figure 1
Gel electrophoresis profile of the TRBP-interacting proteins. (A) Total cell lysates from HeLa cells overexpressing Flag-TRBP were collected and immunoprecipitated with monoclonal anti-Flag agarose. Flag-TRBP and its interacting proteins were eluted with (more ...)
Figure 2
Figure 2
Functional categorization of the TRBP-interacting proteins. Categorization of the molecular function of the 160 TRBP interacting proteins was done using the Ingenuity Pathway Analysis software. The y-axis shows statistical relevance of the TRBP-interacting (more ...)
Table 1
Table 1
Functional categories of the TRBP-associated complex
Although previous reports implicated TRBP as active primarily in the cytoplasm, our mass spectrometry results (Additional file 2. Supplementary Materials and Methods) identified several TRBP-interacting nuclear factors which are known to participate in processes including RNA splicing, cellular growth and proliferation and gene transcription (Figure (Figure2,2, Table Table1;1; and Additional file 1, Table S1). For example, EFTUD2, HNRPC, PRPF8, PTBP1, SFRS1, SYNCRIP, SNRPD1, SNRPD3 and U2AF1 are components of the small nuclear ribonucleoprotein (snRNPs) that are involved in splicing of pre-mRNAs. Related to gene transcription, TRBP-associated proteins include those found to be active in RNA polymerase II- and III-dependent transcription (Additional file 1, Table S1). Additionally, a TRBP-associated factor, Sox21, is a HMG-box transcription factor that acts in a complex array of repressive and activating transcriptional processes in embryonic stem cells [27]. The transcription co-activator HMGA1 was also identified in our proteomic data (Table (Table1).1). Whether TRBP participates in the determination of pluripotency through Sox21 requires further study.
Recently, TRBP truncating mutations were found in human cancers with microsatellite instability [28]. Evidence exists which supports the notion that impaired miRNA processing and destabilization of the DICER1 protein are correlated with tumorigenesis [28]. Because TRBP is known to interact with Dicer and to be involved in mRNA processing, how TRBP and TRBP-interacting proteins contribute to oncogenesis merits future investigation. The current TRBP proteome provides a starting point for initiating those explorations. Our study describes the TRBP-proteome in HeLa cells. Although TRBP was originally identified as the HIV-1 TAR RNA-binding protein, its more recently characterized function in microRNA biogenesis and RISC-activity is widely conserved in all cell types (e.g. epithelial, hematopoietic, mesenchymal cells etc...). Thus, a HeLa-like TRBP-proteome is likely to be found in all types of human cells. We realize that systematic functional validation of the currently identified TRBP proteome will be necessary in order to clarify the biological relevance of each factor. Indeed, some of the TRBP-interacting proteins are being currently characterized.
Abbreviations
TRBP: TAR-RNA binding protein 2; RISC: RNA-induced silencing complex; TAR: trans-activation responsive element.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
YHC constructed the TRBP expression plasmid, performed co-immunoprecipitations, prepared MS samples, analyzed the results; OJS provided mass spectrometry analyses; KTJ conceived of the study. YHC and KTJ prepared the manuscript. All authors read and approved the final manuscript.
Supplementary Material
Additional file 1
Supplementary Table S1. Pubmed ID, gene name, functional description, hits in proteomics study and alternative symbol for TRBP-interacting factors.
Additional file 2
Supplementary Materials and Methods.
Acknowledgements
Work in the KTJ laboratory was supported in part by NIAID/NIH intramural funds and by the Intramural AIDS Targeted Anti-viral Program (IATAP).
  • Garzon R, Fabbri M, Cimmino A, Calin GA, Croce CM. MicroRNA expression and function in cancer. Trends Mol Med. 2006;12:580–587. doi: 10.1016/j.molmed.2006.10.006. [PubMed] [Cross Ref]
  • Svoboda P, Flemr M. The role of miRNAs and endogenous siRNAs in maternal-to-zygotic reprogramming and the establishment of pluripotency. EMBO Rep. 2010;11:590–597. doi: 10.1038/embor.2010.102. [PubMed] [Cross Ref]
  • Lewis MA, Steel KP. MicroRNAs in mouse development and disease. Semin Cell Dev Biol. 2010;21:774–780. doi: 10.1016/j.semcdb.2010.02.004. [PMC free article] [PubMed] [Cross Ref]
  • Yeung ML, Bennasser Y, Jeang KT. miRNAs in the biology of cancers and viral infections. Curr Med Chem. 2007;14:191–197. doi: 10.2174/092986707779313417. [PubMed] [Cross Ref]
  • Berkhout B, Jeang KT. RISCy business: MicroRNAs, pathogenesis, and viruses. J Biol Chem. 2007;282:26641–26645. doi: 10.1074/jbc.R700023200. [PubMed] [Cross Ref]
  • Watanabe Y, Kishi A, Yachie N, Kanai A, Tomita M. Computational analysis of microRNA-mediated antiviral defense in humans. FEBS Lett. 2007;581:4603–4610. doi: 10.1016/j.febslet.2007.08.049. [PubMed] [Cross Ref]
  • Yeung ML, Benkirane M, Jeang KT. Small non-coding RNAs, mammalian cells, and viruses: regulatory interactions? Retrovirology. 2007;4:74. doi: 10.1186/1742-4690-4-74. [PMC free article] [PubMed] [Cross Ref]
  • Grassmann R, Jeang KT. The roles of microRNAs in mammalian virus infection. Biochim Biophys Acta. 2008;1779:706–711. [PMC free article] [PubMed]
  • Triboulet R, Mari B, Lin YL, Chable-Bessia C, Bennasser Y, Lebrigand K. et al. Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science. 2007;315:1579–1582. doi: 10.1126/science.1136319. [PubMed] [Cross Ref]
  • Chable-Bessia C, Meziane O, Latreille D, Triboulet R, Zamborlini A, Wagschal A. et al. Suppression of HIV-1 replication by microRNA effectors. Retrovirology. 2009;6:26. doi: 10.1186/1742-4690-6-26. [PMC free article] [PubMed] [Cross Ref]
  • Strebel K, Luban J, Jeang KT. Human cellular restriction factors that target HIV-1 replication. BMC Med. 2009;7:48. doi: 10.1186/1741-7015-7-48. [PMC free article] [PubMed] [Cross Ref]
  • Jaskiewicz L, Filipowicz W. Role of Dicer in posttranscriptional RNA silencing. Curr Top Microbiol Immunol. 2008;320:77–97. full_text. [PubMed]
  • Ambros V. The functions of animal microRNAs. Nature. 2004;431:350–355. doi: 10.1038/nature02871. [PubMed] [Cross Ref]
  • Haase AD, Jaskiewicz L, Zhang H, Laine S, Sack R, Gatignol A. et al. TRBP, a regulator of cellular PKR and HIV-1 virus expression, interacts with Dicer and functions in RNA silencing. EMBO Rep. 2005;6:961–967. doi: 10.1038/sj.embor.7400509. [PubMed] [Cross Ref]
  • Chendrimada TP, Gregory RI, Kumaraswamy E, Norman J, Cooch N, Nishikura K. et al. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature. 2005;436:740–744. doi: 10.1038/nature03868. [PMC free article] [PubMed] [Cross Ref]
  • Kok KH, Ng MH, Ching YP, Jin DY. Human TRBP and PACT directly interact with each other and associate with dicer to facilitate the production of small interfering RNA. J Biol Chem. 2007;282:17649–17657. doi: 10.1074/jbc.M611768200. [PubMed] [Cross Ref]
  • Daniels SM, Melendez-Pena CE, Scarborough RJ, Daher A, Christensen HS, El FM. et al. Characterization of the TRBP domain required for dicer interaction and function in RNA interference. BMC Mol Biol. 2009;10:38. doi: 10.1186/1471-2199-10-38. [PMC free article] [PubMed] [Cross Ref]
  • Watashi K, Yeung ML, Starost MF, Hosmane RS, Jeang KT. Identification of small molecules that suppress microRNA function and reverse tumorigenesis. J Biol Chem. 2010;285:24707–24716. doi: 10.1074/jbc.M109.062976. [PubMed] [Cross Ref]
  • Gatignol A, Buckler-White A, Berkhout B, Jeang KT. Characterization of a human TAR RNA-binding protein that activates the HIV-1 LTR. Science. 1991;251:1597–1600. doi: 10.1126/science.2011739. [PubMed] [Cross Ref]
  • Gatignol A, Buckler C, Jeang KT. Relatedness of an RNA-binding motif in human immunodeficiency virus type 1 TAR RNA-binding protein TRBP to human P1/dsI kinase and Drosophila staufen. Mol Cell Biol. 1993;13:2193–2202. [PMC free article] [PubMed]
  • Duarte M, Graham K, Daher A, Battisti PL, Bannwarth S, Segeral E. et al. Characterization of TRBP1 and TRBP2. Stable stem-loop structure at the 5' end of TRBP2 mRNA resembles HIV-1 TAR and is not found in its processed pseudogene. J Biomed Sci. 2000;7:494–506. doi: 10.1007/BF02253365. [PubMed] [Cross Ref]
  • Bennasser Y, Yeung ML, Jeang KT. HIV-1 TAR RNA subverts RNA interference in transfected cells through sequestration of TAR RNA-binding protein, TRBP. J Biol Chem. 2006;281:27674–27678. doi: 10.1074/jbc.C600072200. [PubMed] [Cross Ref]
  • Dorin D, Bonnet MC, Bannwarth S, Gatignol A, Meurs EF, Vaquero C. The TAR RNA-binding protein, TRBP, stimulates the expression of TAR-containing RNAs in vitro and in vivo independently of its ability to inhibit the dsRNA-dependent kinase PKR. J Biol Chem. 2003;278:4440–4448. doi: 10.1074/jbc.M208954200. [PubMed] [Cross Ref]
  • Benkirane M, Neuveut C, Chun RF, Smith SM, Samuel CE, Gatignol A. et al. Oncogenic potential of TAR RNA binding protein TRBP and its regulatory interaction with RNA-dependent protein kinase PKR. EMBO J. 1997;16:611–624. doi: 10.1093/emboj/16.3.611. [PubMed] [Cross Ref]
  • Chendrimada TP, Finn KJ, Ji X, Baillat D, Gregory RI, Liebhaber SA. et al. MicroRNA silencing through RISC recruitment of eIF6. Nature. 2007;447:823–828. doi: 10.1038/nature05841. [PubMed] [Cross Ref]
  • Wilson DN, Nierhaus KH. Ribosomal proteins in the spotlight. Crit Rev Biochem Mol Biol. 2005;40:243–267. doi: 10.1080/10409230500256523. [PubMed] [Cross Ref]
  • Chakravarthy H, Ormsbee BD, Mallanna SK, Rizzino A. Rapid activation of the bivalent gene Sox21 requires displacement of multiple layers of gene-silencing machinery. FASEB J. 2011;25:206–218. doi: 10.1096/fj.10-166926. [PubMed] [Cross Ref]
  • Melo SA, Ropero S, Moutinho C, Aaltonen LA, Yamamoto H, Calin GA. et al. A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function. Nat Genet. 2009;41:365–370. doi: 10.1038/ng.317. [PubMed] [Cross Ref]
Articles from Cell & Bioscience are provided here courtesy of
BioMed Central